Bill Rote
About Bill Rote
Bill Rote serves as the Senior Vice President of Research & Development at Travere Therapeutics, where he has worked since 2017. He has extensive experience in drug discovery and development, with a strong academic background in pharmacology and significant leadership roles in the pharmaceutical industry.
Work at Travere Therapeutics
Bill Rote serves as the Senior Vice President of Research & Development at Travere Therapeutics, a position he has held since 2017. In this role, he oversees various aspects of drug discovery, research operations, and program management. His responsibilities include leading translational research, compound evaluation, and early-stage clinical development. Rote's leadership in these areas has contributed to the company's strategic direction and operational efficiency in the Greater San Diego Area.
Education and Expertise
Bill Rote has an extensive educational background in pharmacology. He earned a Bachelor of Science in Pre-Medicine/Pre-Medical Studies from Penn State University. He furthered his studies at the Penn State College of Medicine, where he achieved a Doctor of Philosophy (Ph.D.) in Pharmacology. Additionally, he completed postdoctoral training in Cardiovascular Pharmacology at the University of Michigan. This academic foundation supports his expertise in drug development and regulatory interactions.
Background in Pharmaceutical Industry
Prior to his current role, Bill Rote held several key positions at Amylin Pharmaceuticals. He served as Vice President, Site Head for Research & Development from 2012 to 2014, and as Vice President of Research & Product Development from 2010 to 2012. His earlier roles at Amylin included Executive Director of the Exenatide Program and Senior Director of Clinical Research. Rote's experience spans over a decade in various leadership roles, focusing on drug discovery and development.
Contributions to Drug Development
Bill Rote has played a significant role in the pharmaceutical industry, contributing to the approval of seven drugs. His efforts have generated substantial revenue, amounting to hundreds of millions of dollars. His broad scientific skills and operational focus have been instrumental in guiding projects through all phases of drug discovery and development, showcasing his capability in translating research into viable therapeutic solutions.
Academic Involvement and Advisory Roles
In addition to his industry experience, Bill Rote maintains an active role in academia. He is a member of the Penn State Biotechnology Advisory Board, a position he has held since 2012. He also engages with Drexel University as a guest lecturer, sharing his expertise in pharmacology and drug development with students. His involvement in these academic settings reflects his commitment to fostering the next generation of professionals in the biotechnology field.